Where does Tesseract Health, Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Tesseract Health, Inc. ranks #30,366 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Tesseract Health, Inc. hold?

Tesseract Health, Inc. holds 9 US utility patents granted between 2019 and 2025, spanning 11 technology areas.

What is Tesseract Health, Inc.'s Innovation Score?

Tesseract Health, Inc. has an Innovation Score of 47.9 out of 100 (top 18% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Tesseract Health, Inc. focus on?

Tesseract Health, Inc.'s top technology area is A61B (DIAGNOSIS; SURGERY; Identification) with 5 patents, ranking #3,118 of 7,127 assignees active in that subclass. Grants appear in 11 CPC subclasses total.

Is Tesseract Health, Inc.'s patent grant rate increasing or decreasing?

Tesseract Health, Inc.'s recent grant velocity is +600% compared to the prior five-year period (grant years, not application filing dates). This indicates accelerating grant output.

What does claim depth mean for Tesseract Health, Inc.'s patents?

Tesseract Health, Inc.'s patents average 13.7 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Tesseract Health, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Tesseract Health, Inc.

USPTO PatentsView assignee record - 9 granted patents across 11 technology areas, recorded in grant years 2019–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61B (DIAGNOSIS; SURGERY; Identification).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Tesseract ranks #30,366 of 49,997 tracked US assignees by granted-patent volume, with 9 patents across 11 technology areas.

#30,366
of 49,997 US assignees by volume: Top 18%
by Innovation Score (47.9/100): 13.7
avg claims per patent: +600%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R30366 · US Corporation #30,366 · 9 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-RICH · TYPE-USCORP · VEL-SURGE · BOOK-FULL

GRANTS-MICRO 9 grants
MID-PACK #30,366/49,997
PHOTO-FINISH Tenaris Connections
CPC-FOCUS A61B · 11 areas
INNOV-PAR 47.9/100
CLAIMS-RICH 13.7 claims/avg
TYPE-USCORP US Corporation
VEL-SURGE +600% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Tenaris Connections Limited (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Tesseract’s 47.9 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 8.0 pts (17%) Velocity 20.0 pts (42%) Breadth 11.7 pts (24%) Claim depth 8.2 pts (17%)

Qualcomm Incorporated · highest

85
Tesseract Health · this assignee

48
3D Lighting… · lowest

7

What this shows Tesseract's Innovation Score is 47.9/100 (top 18% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Tesseract?

Each dot is one of Tesseract’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Tesseract’s own 13.7 claims/patent is at or below the 17.4 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

Tesseract vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Tesseract's grants concentrate

Tesseract Health, Inc. is a focused PatentsView assignee: 11 CPC subclasses with 55.6% of grants classified under A61B (DIAGNOSIS; SURGERY; Identification). Peak complete grant year is 2022 (6 grants) versus a trough of 1 in 2019. By volume, Tesseract sits between Tenaris Connections Limited and Texas LFP, LLC.

Tesseract's three-year grant acceleration

Tesseract Health, Inc. shows 7 grants in 2022–2024 against only 1 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Tenaris Connectio…

9
Teneobio

9
Terran Biosciences

9
Tescan Brno s r o

9
Test Rite Interna…

9
Tetracore

9
Texas Children's…

9
Texas LFP

9
Tesseract Health ◀

9

What this shows Tesseract holds 9 patents at rank #30,384, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Tesseract

By rank, the assignees closest to #30,384 in granted patent volume.

Leaders in A61B (Diagnosis)

Other assignees with the most granted patents in Tesseract's primary technology class.

Tesseract's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

48 Top 18% higher than 82% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2019–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2019–2019 baseline. Full figures in the table below.

View data table

Tesseract Health, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2019	1	11.1%
2022	6	66.7%
2023	1	11.1%
2025partial year	1	11.1%

Which technologies does Tesseract Health, Inc. patent most?

A61B - DIAGNOSIS; SURGERY; Identification 5

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 3

G01B - Measuring Length, Thickness OR Similar Linear DIMENSIONS; Measuring ANGLES; Measuring AREAS; Measuring Irregularities OF Surfaces OR Contours 2

G06V - Image OR Video Recognition OR Understanding 1

F16M - Frames, Casings OR Beds OF Engines, Machines OR Apparatus, NOT Specific TO Engines, Machines OR Apparatus Provided FOR ELSEWHERE; STANDS; Supports 1

G06F - Electric Digital Data Processing 1

H04L - Transmission OF Digital Information, e.g. Telegraphic Communication 1

H02J - Circuit Arrangements OR Systems FOR Supplying OR Distributing Electric POWER; Systems FOR Storing Electric Energy 1

G06N - Computing Arrangements Based ON Specific Computational Models 1

G06T - Image Data Processing OR Generation, IN General 1

G16H - Healthcare Informatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR THE Handling OR Processing OF Medical OR Healthcare Data 1

Top 11 of 11 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Tesseract Health, Inc.'s patent record in context - here's where to go next.

Tesseract Health, Inc.'s lead technology class is A61B (DIAGNOSIS; SURGERY; Identification), 55.6% of its portfolio - see every assignee active in that class. Explore A61B
Ranked #30,366 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Tesseract Health, Inc. against Tenaris Connections Limited, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 47.9/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent , US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.